Undetected carriage explains apparent Staphylococcus aureus acquisition in a non-outbreak healthcare setting.


Journal

The Journal of infection
ISSN: 1532-2742
Titre abrégé: J Infect
Pays: England
ID NLM: 7908424

Informations de publication

Date de publication:
09 2021
Historique:
received: 13 04 2021
revised: 18 07 2021
accepted: 19 07 2021
pubmed: 26 7 2021
medline: 18 9 2021
entrez: 25 7 2021
Statut: ppublish

Résumé

Previous studies have been unable to identify patient or staff reservoirs for the majority of the nosocomial S. aureus acquisitions which occur in the presence of good infection control practice. We set out to establish the extent to which undetected pre-existing carriage explains apparent nosocomial S. aureus acquisition. Over two years elective cardiothoracic admissions were screened for S. aureus carriage before and during hospital admission. Routine screening (nose/groin/wound sampling), was supplemented by sampling additional body sites (axilla/throat/rectum) and culture-based methods optimised to detect fastidious phenotypes (small colony variants, cell wall deficient variants) and molecular identification by PCR. 35% of participants (53/151) were S. aureus carriers according to routine pre-healthcare screening; increasing to 42% (63/151) when additional body sites and enhanced cultures were employed. 71% (5/7) of apparent acquisitions were explained by pre-existing carriage using augmented measures. Enhanced culture identified a minority of colonised individuals (3/151 including 1 MRSA carrier) who were undetected by routine and additional screening cultures. 4/14 (29%) participants who became culture-negative during admission had S. aureus genomic material detected at discharge. Conventional sampling under-estimates carriage of S. aureus and this explains the majority of apparent S. aureus acquisitions among elective cardiothoracic patients.

Identifiants

pubmed: 34303737
pii: S0163-4453(21)00358-3
doi: 10.1016/j.jinf.2021.07.016
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

332-338

Informations de copyright

Copyright © 2021. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest All authors have completed the Unified Competing Interest form (available on request from the corresponding author) and declare: no support from any organization for the submitted work; no authors received personal fees in the past three years outside the submitted work; no other relationships or activities that could appear to have influenced the submitted work.

Auteurs

James R Price (JR)

Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Falmer, Brighton, BN1 9PS, United Kingdom. Electronic address: james.price5@nhs.net.

Maho Yokoyama (M)

Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Falmer, Brighton, BN1 9PS, United Kingdom. Electronic address: M.Yokoyama@bsms.ac.uk.

Kevin Cole (K)

Public Health England, Royal Sussex County Hospital, Brighton, BN2 5BE, United Kingdom. Electronic address: kevin-cole@live.co.uk.

Jonathan Sweetman (J)

Clinical Investigation Research Unit, Brighton and Sussex University Hospital NHS Trust, Brighton, BN2 5BE, United Kingdom. Electronic address: Jonathan.Sweetman@nhs.net.

Laura Behar (L)

Clinical Investigation Research Unit, Brighton and Sussex University Hospital NHS Trust, Brighton, BN2 5BE, United Kingdom. Electronic address: l.behar@nhs.net.

Simon Stoneham (S)

Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Falmer, Brighton, BN1 9PS, United Kingdom. Electronic address: simon.stoneham@nhs.net.

Daire Cantillon (D)

Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Falmer, Brighton, BN1 9PS, United Kingdom. Electronic address: D.Cantillon2@bsms.ac.uk.

Simon J Waddell (SJ)

Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Falmer, Brighton, BN1 9PS, United Kingdom. Electronic address: S.Waddell@bsms.ac.uk.

Jonathan Hyde (J)

Clinical Investigation Research Unit, Brighton and Sussex University Hospital NHS Trust, Brighton, BN2 5BE, United Kingdom. Electronic address: Jonathan.Hyde@nhs.net.

Ruhina Alam (R)

Clinical Investigation Research Unit, Brighton and Sussex University Hospital NHS Trust, Brighton, BN2 5BE, United Kingdom. Electronic address: Ruhina.Alam@nhs.net.

Derrick Crook (D)

Department of Experimental Medicine, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom. Electronic address: derrick.crook@ndcls.ox.ac.uk.

John Paul (J)

Public Health England, Royal Sussex County Hospital, Brighton, BN2 5BE, United Kingdom. Electronic address: John.Paul@phe.gov.uk.

Martin J Llewelyn (MJ)

Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Falmer, Brighton, BN1 9PS, United Kingdom. Electronic address: M.J.Llewelyn@bsms.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH